Patents by Inventor Daniel P. Rossignol

Daniel P. Rossignol has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating alcoholic liver disease
    Patent number: 5952309
    Abstract: A method for the inhibition and amelioration of alcholic liver disease in a mammal in need of such treatment by administering novel analogs of Lipid A which act as endotoxin antagonists. These antagonists compounds are found to inhibit the swift increase in alcohol metabolism which typically accompanies ingestion of alcohol and which may lead to the pathophysiological abnormalities associated with alcoholic liver disease.
    Type: Grant
    Filed: September 27, 1996
    Date of Patent: September 14, 1999
    Assignee: Eisai Company, Ltd.
    Inventors: Daniel P. Rossignol, Ronald G. Thurman, William J. Christ, Michael D. Lewis
  • Substituted liposaccharides useful in the treatment and prevention of endotoxemia
    Patent number: 5935938
    Abstract: Novel substituted liposaccharides useful as in the prophylactic and affirmative treatment of endotoxemia including sepsis, septicemia and various forms of septic shock and methods of using these agents are provided. Also provided are methods of preparing these agents and intermediates useful therein.
    Type: Grant
    Filed: June 5, 1996
    Date of Patent: August 10, 1999
    Assignee: Eisai Co., Ltd.
    Inventors: William J. Christ, Daniel P. Rossignol, Seiichi Kobayashi, Tsutomu Kawata
  • Anti-endotoxin compounds
    Patent number: 5843918
    Abstract: Disclosed are lipid A analogs useful for the treatment of septic shock and LPS-mediated activation of viral infection.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 1, 1998
    Assignee: Eisai Co., Ltd.
    Inventors: William J. Christ, Lynn D. Hawkins, Tsutomu Kawata, Daniel P. Rossignol, Seiichi Kobayashi, Osamu Asano
  • Anti-endotoxin compounds
    Patent number: 5756718
    Abstract: Disclosed are lipid A analogs useful for the treatment of septic shock and LPS-mediated activation of viral infection.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 26, 1998
    Assignee: Eisai Co., Ltd.
    Inventors: William J. Christ, Lynn D. Hawkins, Tsutomu Kawata, Daniel P. Rossignol, Seiichi Kobayashi, Osamu Asano
  • Substituted liposaccharides useful in the treatment and prevention of endotoxemia
    Patent number: 5750664
    Abstract: Novel substituted liposaccharides useful as in the prophylactic and affirmative treatment of endotoxemia including sepsis, septicemia and various forms of septic shock and methods of using these agents are provided. Also provided are methods of preparing these agents and intermediates useful therein.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: May 12, 1998
    Assignee: Eisai Co., Ltd.
    Inventors: William J. Christ, Daniel P. Rossignol, Seiichi Kobayashi, Tsutomu Kawata
  • Substituted liposaccharides useful in the treatment and prevention of endotoxemia
    Patent number: 5681824
    Abstract: Novel substituted liposaccharides useful as in the prophylactic and affirmative treatment of endotoxemia including sepsis, septicemia and various forms of septic shock and methods of using these agents are provided. Also provided are methods of preparing these agents and intermediates useful therein.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: October 28, 1997
    Assignee: Eisai Co., Ltd.
    Inventors: William J. Christ, Daniel P. Rossignol, Seiichi Kobayashi, Tsutomu Kawata
  • Anti-endotoxin compounds
    Patent number: 5612476
    Abstract: Disclosed are lipid A analogs useful for the treatment of septic shock and LPS-mediated activation of viral infection.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 18, 1997
    Assignee: Eisai Co., Ltd.
    Inventors: William J. Christ, Lynn D. Hawkins, Tsutomu Kawata, Daniel P. Rossignol, Seiichi Kobayashi, Osamu Asano
  • Anti-endotoxin compounds
    Patent number: 5530113
    Abstract: Disclosed are lipid A analogs useful for the treatment of septic shock and LPS-mediated activation of viral infection.
    Type: Grant
    Filed: August 25, 1992
    Date of Patent: June 25, 1996
    Assignee: Eisai Co., Ltd.
    Inventors: William J. Christ, Lynn D. Hawkins, Tsutomu Kawata, Daniel P. Rossignol, Seiichi Kobayashi, Osamu Asano